DAIC Articles

Jun 2, 2021 | DAIC Articles
Bracco Moving Forward With HLT Meridian TAVR Valve

The HLT Meridian TAVR Valve System is designed to overcome some of the challenges of current FDA-cleared TAVR devices.

May 19, 2021 | DAIC Articles
ECMO Increased Survival in Refractory Out-of-Hospital Cardiac Arrest

This “hyperinvasive” approach performed better than expected outcomes also seen in patients who received standard advanced cardiac life support.

May 10, 2021 | DAIC Articles
Vendors and ACC Collaborate With Consumer Technology Association to Help Clinicians and Patients Understand Cardiovascular Devices

The Consumer Technology Association (CTA) is collaborating with the American College of Cardiology (ACC) and several vendors on best practices for device and app and wearable device makers to provide deeper understanding of products that manage cardiovascular health.

Apr 21, 2021 | DAIC Articles
Creating a Structural Heart Program is an Investment in the Future of the Hospital

Today, as TAVR now makes up more procedural volume in the U.S. than surgical aortic replacements, many hospitals that have not already created a structural heart program are now looking at creating one.

Apr 19, 2021 | DAIC Articles
Gene Therapy for Atrial Fibrillation Will Be Investigated With $3.67 million NIH Grant

National Heart, Lung, and Blood Institute (NHLBI) has awarded a grant of $462,689 to Rhythm Therapeutics Inc. (RTI) to complete the phase 1 segment of the development of a novel gene therapy to treat atrial fibrillation (AF). It involves using electroporation to create temporary openings in cardiac cells to deliver therapeutic transgenes targeting the underlying […]

Apr 14, 2021 | DAIC Articles
First Patient Treated in Elixer Dynamx Coronary Bioadaptor Stent Technology

Elixir Medical recently announced the first patient was treated in the BIOADAPTOR randomized controlled trial (RCT) of the DynamX Coronary Bioadaptor System, the first drug-eluting coronary stent that adapts to vessel physiology.

Apr 12, 2021 | DAIC Articles
Medtronic Recalls its ICDs and CRT-Ds Due to Risk of Rapid Battery Depletion

Class I recall includes Evera, Viva, Brava, Claria, Amplia, Compia and Visia implantable cardioverter defibrillators and cardiac resynchronization therapy devices.

Apr 1, 2021 | DAIC Articles
Single-Database Cardiology Platform Drives Efficient Workflow and Improves Data Access

In the early 2000s, the cardiology department at WHS Washington Hospital needed to replace an outdated paper reporting system with a modern system that could streamline workflows, reduce redundant data entry, and balance workloads.

Mar 26, 2021 | DAIC Articles
FDA Clears First Device to Treat Right Ventricular Outflow Tract Congenital Heart Disease

New RVOT repair device provides less invasive option to treat pulmonary valve regurgitation for patients with a native or surgically-repaired right ventricular outflow tract.

Mar 9, 2021 | DAIC Articles
Large Bore Closure in Structural Heart Interventions

While many cardiac and vascular procedures have largely moved to minimally invasive techniques, the size of these transcatheter devices has required larger arterial access introducer sheaths, leading to increases in vascular and bleeding complications. Large bore devices are generally considered anything 10 French and bigger. This growth in large bore interventions has led to a […]

Filter by Journal